The COVID-19 chemoprophylactic conundrum: Are we limiting available resources?

Dermatol Ther. 2020 Jul;33(4):e13607. doi: 10.1111/dth.13607. Epub 2020 Jun 9.

Authors

Aseem Sharma¹, Madhulika Mhatre², Mohamad Goldust^{3

4}, Veenu Jindal⁵, Palvi Singla⁶

Affiliations

¹ Department of Dermatology, LTM General Hospital, Mumbai, India.
² Department of Dermatology, Wockhardt Hospital, Mumbai, India.
³ Department of Dermatology, University of Rome, G. Marconi, Rome, Italy.
⁴ Department of Dermatology, University Hospital Basel, Basel, Switzerland.
⁵ Department of Dermatology, Clinic Dermatech, New Delhi, India.
⁶ Department of Dermatology, Dayanand Medical College, Ludhiana, India.

No abstract available

Publication types

Letter

MeSH terms

Antiviral Agents / pharmacology*
Betacoronavirus*
COVID-19
Coronavirus Infections / epidemiology
Coronavirus Infections / prevention & control*
Health Resources / supply & distribution*
Humans
Pandemics / prevention & control*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / prevention & control*
SARS-CoV-2

Substances

Antiviral Agents